Evidence map›Paper›PMID 31533758›Full record

ArticleOrphanet journal of rare diseases2019

Ocular manifestations in Gorlin-Goltz syndrome.

Antonietta Moramarco, Ehud Himmelblau, Emanuele Miraglia, Fabiana Mallone, Vincenzo Roberti, Federica Franzone, Chiara Iacovino, Sandra Giustini, Alessandro Lambiase

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. BMC women's health · 2024
    Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Strabismus in Genetic Syndromes: A Review.Clinical & experimental ophthalmology · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. [Gorlin-Goltz syndrome-not just a syndrome of malignant eyelid tumors].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2022
    Article
  12. Article
  13. Genetic Insight into Gorlin-Goltz Syndrome.Indian journal of dermatology
    Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Antonietta MoramarcoDepartment of Sense Organs, Faculty of Medicine and Odontology, Sapienza University of Rome, Rome, Italy. antonietta.moramarco@uniroma1.it.ORCID 0000-0001-9516-438X
Ehud HimmelblauDepartment of Sense Organs, Faculty of Medicine and Odontology, Sapienza University of Rome, Rome, Italy. himmelblau50@hotmail.com.
Emanuele MiragliaDepartment of Internal Medicine and Medical Specialties, Unit of Dermatology, Sapienza University of Rome, Rome, Italy.
Fabiana MalloneDepartment of Sense Organs, Faculty of Medicine and Odontology, Sapienza University of Rome, Rome, Italy.
Vincenzo RobertiDepartment of Internal Medicine and Medical Specialties, Unit of Dermatology, Sapienza University of Rome, Rome, Italy.
Federica FranzoneDepartment of Sense Organs, Faculty of Medicine and Odontology, Sapienza University of Rome, Rome, Italy.
Chiara IacovinoDepartment of Internal Medicine and Medical Specialties, Unit of Dermatology, Sapienza University of Rome, Rome, Italy.
Sandra GiustiniDepartment of Internal Medicine and Medical Specialties, Unit of Dermatology, Sapienza University of Rome, Rome, Italy.
Alessandro LambiaseDepartment of Sense Organs, Faculty of Medicine and Odontology, Sapienza University of Rome, Rome, Italy.
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGorlin-Goltz syndrome, also known as nevoid basal cell carcinoma syndrome, is a rare genetic disorder that is transmitted in an autosomal dominant manner with complete penetrance and variable expressivity. It is caused in 85% of the cases with a known etiology by pathogenic variants in the PTCH1 gene, and is characterized by a wide range of developmental abnormalities and a predisposition to multiple neoplasms. The manifestations are multiple and systemic and consist of basal cell carcinomas in various regions, odontogenic keratocistic tumors and skeletal anomalies, to name the most frequent. Despite the scarce medical literature on the topic, ocular involvement in this syndrome is frequent and at the level of various ocular structures. Our study focuses on the visual apparatus and its annexes in subjects with this syndrome, in order to better understand how this syndrome affects the ocular system, and to evaluate with greater accuracy and precision the nature of these manifestations in this group of patients.

resultsOur study confirms the presence of the commonly cited ocular findings in the general literature regarding the syndrome [hypertelorism (45.5%), congenital cataract (18%), nystagmus (9%), colobomas (9%)] and highlights strabismus (63% of the patients), epiretinal membranes (36%) and myelinated optic nerve fiber layers (36%) as the most frequent ophthalmological findings in this group of patients.

conclusionsThe presence of characteristic and frequent ocular signs in the Gorlin- Goltz syndrome could help with the diagnostic process in subjects suspected of having the syndrome who do not yet have a diagnosis. The ophthalmologist has a role as part of a multidisciplinary team in managing these patients. The ophthalmological follow-up that these patients require, can allow, if necessary, a timely therapy that could improve the visual prognosis of such patients.

Indexed as

AdolescentAdultAgedBasal Cell CarcinomaBasal Cell Nevus SyndromeCataractColobomaEye DiseasesFemaleHumansHypertelorismMaleMiddle AgedPatched-1 ReceptorYoung AdultPatched-1 ReceptorPTCH1 protein, humanGorlin-Goltz syndromeGorlin syndromeMyelinated optical nerve fiber layersNevoid basal cell carcinoma syndromeOcular anomaliesOdontogenic keratocyst

Identifiers

PMID31533758
PMCPMC6749644
OpenAlexW2973673354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.